Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (31-40 of 573) with videos related to

Pageof 58
Sort By:
Clinical Microbiology Reviews|October 15, 2005
Extended-spectrum beta-lactamases: a clinical updateDavid L Paterson, Robert A Bonomo
The Journal of Antibiotics|March 11, 2020
Antibiotics in the clinical pipeline in October 2019Mark S Butler, David L Paterson
Infectious Disease Clinics of North America|May 22, 2016
Multidrug-Resistant Bacteria in the Community: Trends and Lessons LearnedDavid van Duin, David L Paterson
Annals of Internal Medicine|October 26, 2021
Letter From Australia: A Never-Ending Pandemic?David L Paterson, Claire M Rickard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2006
Parenteral and inhaled colistin for treatment of ventilator-associated pneumoniaPeter K Linden, David L Paterson
Expert Opinion on Pharmacotherapy|July 7, 2021
How urgent is the need for new antifungals?Adam G Stewart, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Modifying antibiotic prescribing in primary careAnton Y Peleg, David L Paterson
Expert Review of Anti-Infective Therapy|December 7, 2013
The spread and acquisition of NDM-1: a multifactorial problemAlexander M Wailan, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2010
How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infectionDavid L Paterson, Benjamin A Rogers
Chest|September 18, 2007
Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumoniaBrian A Potoski, David L Paterson
Pageof 58

Showing results (31-40 of 573) with videos related to

Sort By:
Pageof 58
Clinical Microbiology Reviews|October 15, 2005
Extended-spectrum beta-lactamases: a clinical updateDavid L Paterson, Robert A Bonomo
The Journal of Antibiotics|March 11, 2020
Antibiotics in the clinical pipeline in October 2019Mark S Butler, David L Paterson
Infectious Disease Clinics of North America|May 22, 2016
Multidrug-Resistant Bacteria in the Community: Trends and Lessons LearnedDavid van Duin, David L Paterson
Annals of Internal Medicine|October 26, 2021
Letter From Australia: A Never-Ending Pandemic?David L Paterson, Claire M Rickard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2006
Parenteral and inhaled colistin for treatment of ventilator-associated pneumoniaPeter K Linden, David L Paterson
Expert Opinion on Pharmacotherapy|July 7, 2021
How urgent is the need for new antifungals?Adam G Stewart, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Modifying antibiotic prescribing in primary careAnton Y Peleg, David L Paterson
Expert Review of Anti-Infective Therapy|December 7, 2013
The spread and acquisition of NDM-1: a multifactorial problemAlexander M Wailan, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2010
How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infectionDavid L Paterson, Benjamin A Rogers
Chest|September 18, 2007
Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumoniaBrian A Potoski, David L Paterson
Pageof 58